Results 31 to 40 of about 1,414 (186)
Drug Design, Development and Therapy, 2018 Yuting Peng, Xiongze Zhang, Miaoling Li, Bing Liu, Lan Mi, Chengguo Zuo, Feng Wen State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China Introduction: To evaluate the functional and morphological ...
Peng Y +6 more
doaj +1 more source
Journal of Ophthalmology, 2018 Introduction. To compare the effect and safety of intravitreal conbercept (IVC), intravitreal ranibizumab (IVR), or intravitreal triamcinolone acetonide (IVTA) injection on 23-gauge (23-G) pars plana vitrectomy (PPV) for proliferative diabetic ...
Jinglin Cui +8 more
doaj +2 more sources
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
BMC OphthalmologyBackground This study aims to evaluate the two-year outcomes of polypoidal choroidal vasculopathy (PCV) treated with conbercept and to investigate the predictive response factors.
Yang Liu +4 more
doaj +2 more sources
Frontiers in Pharmacology, 2021 Intravitreal injections of anti-vascular endothelial growth factor (VEGF) have become increasingly popular in the treatment of ocular diseases. However, few studies have determined the efficiency of unilateral intravitreal anti-VEGF injection in the ...
Yu Di, Haiyan Xu, Junjie Ye, Zijian Guo
doaj +1 more source
Proteomic analysis of anti-angiogenic effects by conbercept in the mice with oxygen induced retinopathy [PDF]
International Journal of Ophthalmology, 2020 AIM: To analyze the retinal proteomes with and without conbercept treatments in mice with oxygen-induced retinopathy (OIR) and identify proteins involved in the molecular mechanisms mediated by conbercept.
Ji Jin +3 more
doaj +1 more source
Systematic Reviews, 2021 Background The comparative safety and efficacy between anti-vascular endothelial growth factor agents (anti-VEGFs) and between combined therapies for patients with neovascular age-related macular degeneration (nAMD) is unclear.
Andrea C. Tricco +17 more
doaj +1 more source
Conbercept Versus Conbercept Combined with Retinal Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion [PDF]
, 2021 Abstract Background: To evaluate the efficacy of intravitreal injection of conbercept (IVC) with or without laser photocoagulation for recurrent macular edema secondary to branch retinal vein occlusion (BRVO). Methods: 82 patients (82 eyes) with recurrent macular edema secondary to BRVO were collected.
Gengmin Tong +3 more
openaire +1 more source
Effect of subconjunctival injection with conbercept as an adjuvant to filtration surgery for open angle glaucoma: a prospective randomized interventional 6-month follow-up study [PDF]
International Journal of Ophthalmology, 2019 AIM: To compare the safety and efficacy of subconjunctival injection with conbercept and 5-fluorouracil (5-FU) for open angle glaucoma (OAG) patients after filtration surgery.
Jing Zhang +6 more
doaj +1 more source
Frontiers in Medicine, 2022 PurposeTo investigate the intravitreal injection of conbercept as a treatment strategy for proliferative diabetic retinopathy (PDR) with or without center-involved diabetic macular edema (CI-DME) and evaluate its effect on the microvascular changes in ...
Wei Lin +25 more
doaj +1 more source
Subconjunctival conbercept for the treatment of corneal neovascularization
International Journal of Ophthalmology, 2023 AIM: To investigate the effectiveness and safety of subconjunctival injection of conbercept in the treatment of corneal neovascularization (CNV). METHODS: The data on 10 consecutively recruited patients with CNV who received a subconjunctival conbercept (1 mg) once, and measured the area, length, and diameter of neovascularization before and after (1d,
Cun Sun +4 more
openaire +3 more sources